AstraZeneca in AI Collaboration With Immunai to Inform Cancer Drug Trials

(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to...

aldoguerra851@gmail.com aldoguerra851@gmail.com
Sep 26, 2024 - 10:12
28 0
(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to...
Read More